浙江福莱新材料股份有限公司 简式权益变动报告书 浙江福莱新材料股份有限公司 简式权益变动报告书 上市公司名称：浙江福莱新材料股份有限公司 股票上市地点：上海证券交易所 股票简称：福莱新材 股票代码：605488 信息披露义务人一：夏厚君 住所：上海市*** 通讯地址：上海市*** 四、截至本报告书签署之日，除本报告书披露的信息外，上述信息披露义务 人没有通过任何其他方式主动增加或减少其在福莱新材中拥有权益的股份。 五、本次权益变动是根据本报告书所载明的资料进行的。除本报告书披露的 信息外，信息披露义务人没有委托或者授权其它任何人提供未在本报告书中列载 的信息和对本报告书做出任何解释或者说明。 信息披露义务人二：嘉兴市进取企业管理合伙企业（有限合伙） 住所：浙江省嘉兴市嘉善县姚庄镇振兴路 380-10 号 2 单元 2307 室 通讯地址：浙江省嘉兴市嘉善县姚庄镇振兴路 380-10 号 2 单元 2307 室 股份变动性质：持股比例减少 签署日期：2025 年 9 月 8 日 浙江福莱新材料股份有限公司 简式权益变动报告书 信息披露义务人声明 一、信息披露义务人依据《中华人民共和国公司法》《中华人民共和国证券 ...

| 证券代码：605488 | 证券简称：福莱新材 | 公告编号：临 | 2025-122 | | --- | --- | --- | --- | | 债券代码：111012 | 债券简称：福新转债 | | | 浙江福莱新材料股份有限公司 关于控股股东、实际控制人及其一致行动人权益变动 触及 5%整倍数的提示性公告 控股股东夏厚君及其一致行动人嘉兴市进取企业管理合伙企业（有限合伙）保证 向本公司提供的信息真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司董事会及全体董事保证公告内容与信息披露义务人提供的信息一致。 重要内容提示： | 权益变动方向 | 比例增加□ | | 比例减少√ | | --- | --- | --- | --- | | 权益变动前合计比例 | 50.35% | | | | 权益变动后合计比例 | 50.00% | | | | 本次变动是否违反已作出的承 | 是□ | 否√ | | | 诺、意向、计划 | | | | | 是否触发强制要约收购义务 | 是□ | 否√ | | | | √控股股东/实际控制人及其一致行动人 | | --- | --- | | | □其他 5%以上大 ...

格隆汇9月8日丨福莱新材(605488.SH)公布，进取管理公司于2025年9月5日至2025年9月8日间，通过集 中竞价方式减持公司股份99.22万股，占公司总股份的0.35%。公司控股股东、实际控制人夏厚君先生及 其一致行动人进取管理公司合计持股比例由50.35%下降至50.00%，本次权益变动触及5%整数倍。 ...

格隆汇9月8日丨福莱新材(605488.SH)公布，进取管理公司于2025年9月5日至2025年9月8日间，通过集 中竞价方式减持公司股份99.22万股，占公司总股份的0.35%。公司控股股东、实际控制人夏厚君先生及 其一致行动人进取管理公司合计持股比例由50.35%下降至50.00%，本次权益变动触及5%整数倍。 ...

南财智讯9月8日电，福莱新材公告，公司股东夏厚君及其一致行动人嘉兴市进取企业管理合伙企业（有 限合伙）因公司回购注销限制性股票、可转债转股、资本公积金转增股本及减持股份，导致持股比例被 动稀释和持股数量变动。变动后，信息披露义务人合计持有公司140,104,700股股份，占公司总股本的 50.00%。本次权益变动不会导致公司实际控制人发生变化，不存在损害公司及其他股东利益的情形。 截至本报告书签署日，除已披露的减持计划外，信息披露义务人未有明确计划、协议或者安排在未来12 个月内增持或减持上市公司股票的计划。若后续发生相关权益变动事项，信息披露义务人将严格按照相 关法律法规的要求履行信息披露义务。 ...

上市满4年的福莱新材（605488.SH）拟启动第3次融资，本次计划定增7.1亿元用于扩产补流。此时其前 两次募投问题也浮出水面：IPO项目累计效益仅242.73万元，远低于承诺，还变更2亿募资用途；可转债 项目延期一年，截至今年上半年工程进度仅过半。 募投不达预期，折射了福莱新材的主业困境。受市场竞争等影响，公司扣非净利连续3年半下滑，面临 转型压力。然而在去年业绩不达标背景下，公司最新股权激励计划却降低了门槛。加上被视为转型排头 兵的"电子皮肤"业务并未出现在募投项目中，这些都为公司定增解困的前景蒙上一层阴影。 4年3次融资，前次募投不达预期 根据9月3日披露的公告，为满足公司业务发展的资金需求，增强公司资本实力，福莱新材拟向特定对象 发行股票不超过84,062,775股，募集资金不超过7.1亿元，用于"标签标识印刷材料扩产项目""电子级功 能材料扩产升级项目""研发中心升级项目"及"补充流动资金"。 值得一提的是，IPO和可转债融资中，分别有8000万元、1.17亿元用于补流，此次定增公司计划再投入 2.1亿元用于补流，占整体募资金额的25%。 尽管多次募资补流，福莱新材目前仍流动性承压。截至上半年，公 ...

长江商报消息 ●长江商报记者 潘瑞冬 功能性涂布复合材料生产商福莱新材（605488.SH）拟加码新材料升级扩产。 9月2日晚间，福莱新材发布公告称，拟向特定对象发行A股股票，募集资金总额不超过7.1亿元，用于扩 产升级以及补充流动资金。 2025年上半年，福莱新材在柔性传感器领域实现了多项技术突破与商业化进展，并与多个灵巧手和本体 机器人公司开启了批量供货。通过上述定增募投项目的建设，公司将进一步扩充产能，布局下一代产品 研发。 值得一提的是，近一年来，福莱新材搭上人形机器人概念，股价大涨247.58%。 拟定增7.1亿扩产补流 9月2日晚间，福莱新材发布公告称，拟向特定对象发行A股股票，募集资金总额不超过7.1亿元，募集资 金拟用于标签标识印刷材料扩产项目、电子级功能材料扩产升级项目、研发中心升级项目以及补充流动 资金。 此次定增项目包括拟新建标签标识印刷材料产线，全部达产后将新增年产能约77300万平方米。公司表 示，募投项目投产后，有助于公司提升市场份额，推动收入持续增长，为长期稳定发展奠定坚实基础。 福莱新材还拟新建电子级功能材料产线，全部达产后将新增年产能约3700万平方米。电子级功能材料是 福莱 ...

Group 1 - Shengtun Mining plans to repurchase shares worth between 500 million and 600 million yuan, with a maximum repurchase price of 11.82 yuan per share, aimed at employee stock ownership plans or equity incentives [1] - Kangnbei received a drug registration certificate for Linggui Shugan Granules, which is derived from traditional Chinese medicine and is used for treating phlegm and dampness due to Yang deficiency [2] - Zhangjiang Hi-Tech intends to publicly transfer 100% equity and related debts of Shanghai Jixin Rui Construction Technology Co., Ltd. with a total price not less than 151 million yuan [3] Group 2 - Shankai Intelligent won a bid for a metering device procurement project worth 13.318 million yuan from Hohhot Water Supply Company [4] - Hason Co. plans to jointly establish a supply chain company with a registered capital of 10 million yuan, in which Hason will hold a 10% stake [5] - Pudong Construction's subsidiaries won multiple major projects with a total amount of 1.271 billion yuan [6] Group 3 - Jinling Pharmaceutical received approval for the Phase III clinical trial of Olaratogrel tablets, which are used for treating moderate to severe pain associated with endometriosis [8] - Menohua's subsidiary obtained a drug registration certificate for Mosapride Citrate Tablets, aimed at improving gastrointestinal symptoms [10] - Shapuaisi's major shareholder plans to reduce holdings by up to 2% of the company's shares due to personal financial needs [11] Group 4 - Changyuan Power reported an August electricity generation of 3.771 billion kWh, a year-on-year decrease of 6.03% [15][16] - Xibu Livestock's August fresh milk production increased by 4.8% month-on-month but decreased by 7.27% year-on-year [19] - Yong'an Pharmaceutical's actual controller and chairman had their detention lifted, allowing them to resume normal duties [20] Group 5 - Jinkai Intelligent's director resigned due to work adjustments [22] - Xinhua Medical received a Class II medical device registration for an endoscope cleaning workstation [23] - Haishi Science and Technology's innovative drug HSK47388 received approval for a new indication clinical trial [25] Group 6 - Baotai Co. plans to participate in a land use rights auction in Baoji City with a starting price of 57.34 million yuan [26] - Minfeng Special Paper received a government subsidy totaling 11.2 million yuan [27] - Jiuchang Bio obtained a medical device registration for a heparin-binding protein assay kit [29] Group 7 - Jingao Technology plans to repurchase shares worth between 200 million and 400 million yuan, with a maximum price of 17.36 yuan per share [31] - Youxunda won a bid for a metering equipment project from China Southern Power Grid worth approximately 161 million yuan [32] - Qianli Technology reported an August vehicle sales increase of 168.55% year-on-year [32] Group 8 - Guangzhou Port expects an August container throughput increase of 1.2% year-on-year [32] - Kexing Pharmaceutical's GB08 injection completed the first subject enrollment for Phase II clinical trials [33] - Wu Ming Pharmaceutical plans to transfer 98.9% of its subsidiary's shares to a newly established wholly-owned subsidiary [34] Group 9 - Shanghai Electric's acquisition of K-Electric Limited shares has not yet completed the transfer [35] - Fulai New Materials plans to raise no more than 710 million yuan through a private placement [36] - Huaren Health's drug registration application for a new type of potassium ion competitive acid blocker has been accepted [37]

Core Viewpoint - The company, Fule New Materials, plans to raise up to 710 million yuan through a private placement of A-shares to fund expansion projects in label printing materials, electronic-grade functional materials, R&D center upgrades, and to supplement working capital [2]. Group 1: Fundraising and Project Allocation - The total investment for the projects is approximately 840.84 million yuan, with the raised funds allocated as follows: 243.2 million yuan for label printing materials expansion, 220.5 million yuan for electronic-grade functional materials upgrade, 36.3 million yuan for R&D center upgrades, and 210 million yuan for working capital [3]. - The electronic-grade functional materials project will be implemented in Jiaxing, Zhejiang, with an expected annual production capacity of about 37 million square meters upon completion [3][4]. Group 2: Project Details and Market Position - The electronic-grade functional materials market is dominated by international giants like 3M and Nitto Denko. The company aims to produce high-value materials such as OLED support films and folding protective films, leveraging its proprietary technologies to capture the domestic replacement market [4]. - The label printing materials expansion project is expected to add an annual production capacity of approximately 773 million square meters, including the purchase of coating machines and smart upgrades to existing production lines [4]. Group 3: R&D and Financial Performance - The R&D center upgrade will involve the establishment of a high-cleanliness laboratory and the acquisition of precision R&D equipment to enhance the development of high-end materials for OLED displays and flexible sensors [5]. - In the first half of 2025, the company reported a revenue of 1.334 billion yuan, a year-on-year increase of 15.4%, while the net profit attributable to shareholders decreased by 19.58% to 50.93 million yuan [5].

9月3日，福莱新材跌5.06%，截至发稿，报31.71元/股，成交2.51亿元，换手率2.79%，总市值88.85亿 元。 数据显示，前海开源基金旗下1只基金位居福莱新材十大流通股东。前海开源嘉鑫混合A（001765）二 季度新进十大流通股东，持有股数132.79万股，占流通股的比例为0.48%。根据测算，今日浮亏损失约 224.41万元。 资料显示，浙江福莱新材料股份有限公司位于浙江省嘉兴市嘉善县姚庄镇利群路269号，成立日期2009 年6月8日，上市日期2021年5月13日，公司主营业务涉及功能性涂布复合材料的研发、生产和销售。主 营业务收入构成为：广告喷墨打印材料46.65%，标签标识印刷材料31.42%，其他9.17%，功能基膜材料 6.94%，电子级功能材料3.95%，其他(补充)1.86%。 前海开源嘉鑫混合A（001765）成立日期2016年12月26日，最新规模3亿。今年以来收益73.01%，同类 排名183/8180；近一年收益80.86%，同类排名754/7967；成立以来收益169.57%。 从福莱新材十大流通股东角度 前海开源嘉鑫混合A（001765）基金经理为吴国清。 截至发稿，吴国 ...